Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1992-10-29
|
pubmed:abstractText |
N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide (FANFT) administration to rats followed by sodium saccharin results in transitional cell carcinomas of the bladder, of which 24% harbor an activated H-ras gene. Since 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) is the mutagenic and carcinogenic metabolite of FANFT in vivo, we wished to examine ras activation in in vitro ANFT-transformed rat bladder epithelial cells as well as four cell lines established in culture from in vivo FANFT-induced rat bladder tumors. Screening by Western blotting revealed no enhanced levels of p21ras in ANFT-transformed cells nor in cells established in culture from FANFT-induced rat bladder carcinomas. Further investigations using immunohistochemical staining with a different pan-reactive p21 monoclonal antibody (Cetus Corporation) specific for this method, however, showed two groups of cells from FANFT-induced rat bladder tumors had enhanced immunoreactivity. Apart from this, p21ras expression of most of the cells groups varied little from the controls. We examined the reported hot spots (exons 1 and 2) of each of the ras genes (H-, K- and N-ras) by direct sequencing of amplified DNA. No mutations were present. We conclude, therefore, that ANFT transformation of primary rat bladder epithelial cells in vitro may not in this case be mediated by ras activation, although this is difficult to determine since others have observed that optimal culture conditions can select for certain populations of cells without ras activation.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ANFT,
http://linkedlifedata.com/resource/pubmed/chemical/Carcinogens,
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/FANFT,
http://linkedlifedata.com/resource/pubmed/chemical/Oligonucleotides
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0143-3334
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:geneSymbol |
H-ras
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1651-5
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:1394851-Animals,
pubmed-meshheading:1394851-Base Sequence,
pubmed-meshheading:1394851-Blotting, Western,
pubmed-meshheading:1394851-Carcinogens,
pubmed-meshheading:1394851-Cell Transformation, Neoplastic,
pubmed-meshheading:1394851-Cells, Cultured,
pubmed-meshheading:1394851-DNA,
pubmed-meshheading:1394851-Epithelial Cells,
pubmed-meshheading:1394851-FANFT,
pubmed-meshheading:1394851-Genes, ras,
pubmed-meshheading:1394851-Immunohistochemistry,
pubmed-meshheading:1394851-Molecular Sequence Data,
pubmed-meshheading:1394851-Oligonucleotides,
pubmed-meshheading:1394851-Polymerase Chain Reaction,
pubmed-meshheading:1394851-Rats,
pubmed-meshheading:1394851-Urinary Bladder,
pubmed-meshheading:1394851-Urinary Bladder Neoplasms
|
pubmed:year |
1992
|
pubmed:articleTitle |
Ras involvement in cells transformed with 2-amino-4-(5-nitro-2-furyl)thiazole (ANFT) in vitro and with N-[4-(5-nitro-2-furyl)-2-thiazoyl]formamide in vivo.
|
pubmed:affiliation |
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha 68198-3135.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|